Connection
Kelly Faulk to Immunoconjugates
This is a "connection" page, showing publications Kelly Faulk has written about Immunoconjugates.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.602 |
|
|
|
-
Faulk KE, Sopfe JM, Campbell K, Liptzin DR, Liu AK, Franklin ARK, Cost CR. Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin. Br J Haematol. 2018 10; 183(2):251-256.
Score: 0.602